Literature DB >> 2533958

Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.

W S Wold1, L R Gooding.   

Abstract

Human adenoviruses are providing insights into strategies that viruses may adopt to evade immune surveillance. There are 47 serotypes that form six groups (A to F) with different genetic and biological properties. Adenovirus type 2 (Ad2) and Ad5, two group C types, the most common and best understood in terms of molecular biology, cause respiratory infections in young children and often form persistent infections. Following infection, the linear duplex DNA genome is expressed in two broad phases: "early", when viral proteins function to usurp the cell; and "late", when viral DNA and structural proteins are synthesized and virions are assembled. One of the early transcription units, region E3, encodes two proteins that appear to counteract different branches of the host's anti-viral defenses. A 19,000 Mr protein called gp19K protects cells against cytolysis by adenovirus-specific cytotoxic T lymphocytes (CTL). Gp19K has two properties that are crucial to this function: it is localized in the endoplasmic reticulum, and it binds strongly to class I antigens of the major histocompatibility complex (MHC). The effect of these two properties is to block transport of class I antigens to the cell surface. In order to lyse adenovirus-infected cells, CTL must recognize adenovirus peptide antigens complexed with class I major histocompatability complex antigens displayed on the cell surface. Since gp19K prevents this, it renders the cell effectively invisible to CTL. The second anti-immune E3 protein is a 14,700 Mr protein called 14.7K. The 14.7K protects adenovirus-infected cells against cytolysis by tumor necrosis factor (TNF). TNF is a pleiotropic immunoregulatory protein that has anti-viral properties and is believed to provide a defense against virus infections. The 14.7K presumably counteracts the anti-viral effects of TNF in vivo. The mechanism of action of the 14.7K is unknown. Further studies on gp19K and 14.7K should assist our understanding of the immune system and adenovirus pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533958

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  18 in total

1.  An adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis complexes with dynein and a small GTPase.

Authors:  S A Lukashok; L Tarassishin; Y Li; M S Horwitz
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes.

Authors:  J M Kaplan; D Armentano; A Scaria; L A Woodworth; S E Pennington; S C Wadsworth; A E Smith; R J Gregory
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I molecules.

Authors:  Jie Fu; Marlene Bouvier
Journal:  Mol Immunol       Date:  2010-11-20       Impact factor: 4.407

4.  Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo.

Authors:  S C Wadsworth; H Zhou; A E Smith; J M Kaplan
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.

Authors:  P Krajcsi; T Dimitrov; T W Hermiston; A E Tollefson; T S Ranheim; S B Vande Pol; A H Stephenson; W S Wold
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Adenovirus E3-19K proteins of different serotypes and subgroups have similar, yet distinct, immunomodulatory functions toward major histocompatibility class I molecules.

Authors:  Jie Fu; Lenong Li; Marlene Bouvier
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

7.  Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes.

Authors:  T W Hermiston; R A Tripp; T Sparer; L R Gooding; W S Wold
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm.

Authors:  P Krajcsi; A E Tollefson; C W Anderson; W S Wold
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor.

Authors:  T S Ranheim; J Shisler; T M Horton; L J Wold; L R Gooding; W S Wold
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane.

Authors:  A R Stewart; A E Tollefson; P Krajcsi; S P Yei; W S Wold
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.